Individuals who did not register for the Conference can now purchase individual session recordings. Anyone who was registered for the Main Conference (October 16-17, 2020) will have access to all recordings, free of any additional charge, through November 15, 2021.
Laura Borgelt, PharmD, MBA, FCCP, BCPS
Professor and Associate Dean of Administration and Operations
University of Colorado Anschutz Medical Campus
Women’s Health Nurse Practitioners (WHNPs), WHNP students, Certified Nurse Midwives (CNMs) and other nurse practitioners and advanced practice clinicians who care for women.
Activity Number: 20-02-19
CE Approval Period: Now through November 15, 2021
Approved CE Credit Hours: 1.25 CE contact hour credit and 0.3 hours of Pharmacology
This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health for 1.25 CE contact hours, including 0.3 hours of pharmacology content.
An estimated 7% of women are using cannabis during pregnancy. Although women may use it for medical reasons such as nausea or vomiting in pregnancy, the prevalence of non-medical use is higher.
Additionally, employees in cannabis dispensaries are recommending cannabis to these women. Many women and healthcare professionals are unaware of the potential risks to the fetus and mother. In this session, we will discuss the effects of cannabis on the endocannabinoid system and fetal development, review studies that have evaluated use of cannabis in pregnancy, and describe counseling opportunities and challenges regarding cannabis use in pregnancy and lactation. Overall, healthcare professionals need to be informed of available data to communicate effectively with patients who may be using or considering use of cannabis during pregnancy and lactation.
At the conclusion of this activity, the learner will be able to:
- Discuss use of cannabis on the endocannabinoid system and fetal development.
- Evaluate studies that have evaluated use of cannabis in pregnancy and lactation.
- Discuss counseling opportunities and challenges regarding cannabis use in pregnancy and lactation.
Laura Borgelt has no reported disclosures
Successful completion of this activity requires the participant to:
- Read the educational objectives, disclosures and disclaimers.
- Watch the session recording
- Complete the session evaluation
- Print your CE certificate (the certificate will be stored on the NPWH E-Learning site under My Transcripts).
- These steps must be completed prior to the course expiration date
- Some courses required a post-test. If a post test is required participants must earn a score of 70%.
Faculty members determine the content of the CE activity. The content does not necessarily represent the views of NPWH. Clinicians are responsible for evaluating information presented in relation to generally accepted standards of care and individual patient characteristics.
This activity has no commercial support
You must be signed in to access this course. You can sign in at the top right-hand corner of the page.
**If you are an NPWH member, were once a member, or have completed CE activities with NPWH in the past, you have a username and password in the system. Please DO NOT create a new account. If you do not remember your username or password, please either click on the “forgot username” or “forgot password” link at the bottom of the sign on screen or call the NPWH office at (202) 543-9693 ext. 81